SCHEMBL5650668

SCHEMBL5650668

NC(=O)[C@H](CCC(=O)O)N(Cc1ccccc1)C(=O)c1cccc(-c2cccs2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.45
PSMB5 P28074 2/20 0.44
TRPM8 Q7Z2W7 3/20 0.42
FFAR1 O14842 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
HTR2A P28223 1/20 0.42
MMP12 P39900 3/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
MMP2 P08253 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
MMP10 P09238 1/20 0.40
MMP9 P14780 1/20 0.40
MMP14 P50281 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
PPARG P37231 2/20 0.39
KAT6A Q92794 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4362591 0.91 HPGDS (0.49) HPGDSPSMB5TRPM8FFAR1MMP12
SCHEMBL5650478 0.88 TRPM8 (0.50) HPGDSTRPM8MMP12MMP2MMP8
SCHEMBL27826145 0.82 TRPM8 (0.46) TRPM8HDAC3HDAC1PPARG
SCHEMBL4623713 0.79 TRPM8 (0.46) TRPM8FFAR1FFAR4PPARG
SCHEMBL4361259 0.78 TRPM8 (0.53) HPGDSTRPM8FFAR1MMP12
SCHEMBL2246723 0.78 MMP12 (0.44) HPGDSTRPM8DRD2DRD4MMP12
SCHEMBL5655902 0.77 MMP12 (0.43) HPGDSTRPM8MMP12MMP2MMP8
SCHEMBL5652505 0.74 KMT2A (0.40) TRPM8HDAC3HDAC1PPARG
SCHEMBL4623203 0.74 NPC1 (0.43) TRPM8PPARG
SCHEMBL2248314 0.74 HPGDS (0.68) HPGDSDRD2DRD4HTR2AMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 HPGDS 1417/4885PSMB5 2033/4885TRPM8 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.